Another New Antibiotic for Skin Infections and Why Infectious Disease Specialists Are Hypocrites

Loren G Miller^{1

2}

Affiliations

¹ Division of Infectious Diseases and Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance.
² David Geffen School of Medicine at the University of California, Los Angeles.

Editorial

Loren G Miller. Clin Infect Dis. 2019.

. 2019 Mar 19;68(7):1223-1224.

doi: 10.1093/cid/ciy720.

Loren G Miller^{1

2}

¹ Division of Infectious Diseases and Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance.
² David Geffen School of Medicine at the University of California, Los Angeles.

No abstract available

Comment on

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.
O'Riordan W, McManus A, Teras J, Poromanski I, Cruz-Saldariagga M, Quintas M, Lawrence L, Liang S, Cammarata S; PROCEED Study Group. O'Riordan W, et al. Clin Infect Dis. 2018 Aug 16;67(5):657-666. doi: 10.1093/cid/ciy165. Clin Infect Dis. 2018. PMID: 29518178 Free PMC article. Clinical Trial.